Pops Diabetes Care reportedly enrolled the first patient in a clinical trial evaluating its Pops! one glucometer, according to the StarTribune.
The Twin Cities-based company is said to be partnering with the Children’s Minnesota healthcare system to study its device in 50 Type I diabetes patients.
